scispace - formally typeset
A

Anna C. Need

Researcher at Imperial College London

Publications -  92
Citations -  11954

Anna C. Need is an academic researcher from Imperial College London. The author has contributed to research in topics: Genome-wide association study & Medicine. The author has an hindex of 43, co-authored 73 publications receiving 10623 citations. Previous affiliations of Anna C. Need include Queen Mary University of London & University College London.

Papers
More filters
Journal ArticleDOI

Hemizygous mutations in L1CAM in two unrelated male probands with childhood onset psychosis.

TL;DR: This is the first study reporting a possible extension of the phenotype of L1CAM variant carriers to childhood onset psychosis and the family history and presence of other significant rare genetic variants in the patients suggest that there may be genetic interactions modulating the presentation.

Multi-Trait Analysis of GWAS and Biological Insights Into Cognition: A Response to Hill (2018)

Max Lam, +64 more
TL;DR: Using empirical data, it is concluded that the MTAG results do not suffer from ‘inflation in the FDR [false discovery rate]’, as suggested by Hill, and are not ‘more relevant to the genetic contributions to education than they are to the Genetic contributions to intelligence’.
Journal ArticleDOI

Pathogenicity of missense variants affecting the collagen IV α5 carboxy non-collagenous domain in X-linked Alport syndrome

TL;DR: In this article , the consequences of missense variants affecting the NC1 domain of the corresponding collagen IV α5 chain were examined in a normal (gnomAD) and other databases (LOVD, Clin Var and 100,000 Genomes Project) to determine their pathogenicity and clinical significance.
Posted ContentDOI

Stretch-activated ion channel TMEM63B associates with developmental and epileptic encephalopathies and progressive neurodegeneration

Annalisa Vetro, +119 more
- 24 Nov 2022 - 
TL;DR: In this paper , the authors describe 16 unrelated patients, with severe early onset developmental and epileptic encephalopathy (DEE), intellectual disability, and severe motor and cortical visual impairment, associated with progressive neurodegenerative brain changes carrying ten distinct de novo variants of TMEM63B.